ARTICLE | Company News
ChemDiv, J&J deal
January 2, 2012 8:00 AM UTC
CRO ChemDiv will use its Discovery outSource technology to identify small molecules against targets to be jointly agreed upon for Johnson & Johnson's Tibotec Pharmaceuticals Ltd. and Janssen Pharmaceu...